ImmunoPET imaging of renal cell carcinoma with 124I-and 89Zr-labeled anti-CAIX monoclonal antibody cG250

被引：0
|
作者：
Stillebroer, Alexander [1 ]
Franssen, Gerben [1 ]
Oyen, Wim [1 ]
Oosterwijk, Egbert [2 ]
Laverman, Peter [1 ]
Mulders, Peter [2 ]
Boerman, Otto [1 ]
机构：
[1] Radboud Univ Nijmegen, Nucl Med, Med Ctr, Nijmegen, Netherlands
[2] Radboud Univ Nijmegen, Urol, Med Ctr, Nijmegen, Netherlands
来源：
JOURNAL OF NUCLEAR MEDICINE | 2010年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
500
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Pharmacokinetic-based treatment planning for fractionated radioimmunotherapy of renal cell cancer with I-131-labeled monoclonal antibody CG250.
    O'Donoghue, JA
    Anwar, K
    Kavanagh, KR
    Larson, SM
    Old, LJ
    Divgi, CR
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (05) : 326P - 326P
  • [42] Preparation, characterization and application of 131I, 186Re, 90Y and 177Lu-labeled cG250 for radioimmunotherapy of renal cell carcinoma.
    Brouwers, AH
    van Eerd, JE
    Oosterwijk, E
    Oyen, WJ
    Corstens, FH
    Boerman, OC
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) : 268P - 269P
  • [43] Phase I/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinoma
    Divgi, CR
    Bander, NH
    Scott, AM
    O'Donoghue, JA
    Sgouros, G
    Welt, S
    Finn, RD
    Morrissey, F
    Capitelli, P
    Williams, JM
    Deland, D
    Nakhre, A
    Oosterwijk, E
    Gulec, S
    Graham, MC
    Larson, SM
    Old, LJ
    CLINICAL CANCER RESEARCH, 1998, 4 (11) : 2729 - 2739
  • [44] 131I-cG250 monoclonal antibody immunoscintigraphy versus [18F]FDG-PET imaging in patients with metastatic renal cell carcinoma:: a comparative study
    Brouwers, AH
    Dörr, U
    Lang, O
    Boerman, OC
    Oyen, WJG
    Steffens, MG
    Oosterwijk, E
    Mergenthaler, HG
    Bihl, H
    Corstens, FHM
    NUCLEAR MEDICINE COMMUNICATIONS, 2002, 23 (03) : 229 - 236
  • [45] Chimeric monoclonal antibody CG250 (Rencarex®) as immunotherapy of renal cell carcinoma:: clinical Phase II summary and current adjuvant Phase III trial in non-metastasized RCC after nephrectomy
    Belldegrun, A
    ANNALS OF ONCOLOGY, 2005, 16 : 18 - 18
  • [46] Targeting of metastatic renal cell carcinoma with the chimeric monoclonal antibody G250 labeled with 131I or 111In:: An intrapatient comparison
    Brouwers, AH
    Buijs, WCAM
    Oosterwijk, E
    Boerman, OC
    Mala, C
    De Mulder, PHM
    Corstens, FHM
    Mulders, PFA
    Oyen, WJG
    CLINICAL CANCER RESEARCH, 2003, 9 (10) : 3953S - 3960S
  • [47] Radionuclide and Fluorescence Imaging of Clear Cell Renal Cell Carcinoma Using Dual Labeled Anti-Carbonic Anhydrase IX Antibody G250
    Muselaers, Constantijn H. J.
    Rijpkema, Mark
    Bos, Desiree L.
    Langenhuijsen, Johan F.
    Oyen, Wim J. G.
    Mulders, Peter F. A.
    Oosterwijk, Egbert
    Boerman, Otto C.
    JOURNAL OF UROLOGY, 2015, 194 (02): : 532 - 538
  • [48] RADIONUCLIDE IMAGING OF METASTASES FROM RENAL-CELL CARCINOMA BY I-131-LABELED ANTI-TUMOR ANTIBODY
    BELITSKY, P
    GHOSE, T
    AQUINO, J
    TAI, J
    MACDONALD, AS
    RADIOLOGY, 1978, 126 (02) : 515 - 517
  • [49] Preclinical immunoPET/CT imaging using Zr-89-labeled anti-PD-L1 monoclonal antibody for assessing radiation-induced PD-L1 upregulation in head and neck cancer and melanoma
    Kikuchi, Masahiro
    Clump, David A.
    Srivastava, Raghvendra M.
    Sun, Lingyi
    Zeng, Dexing
    Diaz-Perez, Julio A.
    Anderson, Carolyn J.
    Edwards, W. Barry
    Ferris, Robert L.
    ONCOIMMUNOLOGY, 2017, 6 (07):
  • [50] Investigation of hypoxia in renal cell carcinoma using PET-CT imaging of 124I-G250 monoclonal antibodies and oxygen tension measurements in a nude mouse model
    Lawrentschuk, N
    Rigopoulos, A
    Mountain, A
    Jones, G
    Lee, FT
    O'Keefe, G
    Davis, ID
    Bolton, DM
    Scott, AM
    JOURNAL OF UROLOGY, 2006, 175 (04): : 121 - 122
12345